Key Takeaways
- COPD patients may have hypoxic respiratory drive; use low-flow oxygen (1-2 L/min) and monitor closely
- Pursed-lip breathing helps COPD patients exhale trapped air and reduce air trapping
- COPD exacerbation treatment: bronchodilators (albuterol), corticosteroids, antibiotics if infection present
- Pneumonia presents with fever, productive cough, crackles, and consolidation on chest X-ray
- Encourage fluids in pneumonia to thin secretions; incentive spirometry and position changes prevent complications
Respiratory Conditions
Respiratory conditions significantly impact oxygenation and ventilation. Nurses must understand the pathophysiology of these conditions to provide appropriate care and prevent life-threatening complications.
Chronic Obstructive Pulmonary Disease (COPD)
COPD is a chronic, progressive lung disease characterized by persistent airflow limitation. It includes chronic bronchitis and emphysema.
Pathophysiology
Chronic Bronchitis:
- Inflammation of bronchial tubes
- Excessive mucus production
- "Blue bloater" appearance (cyanosis, edema)
Emphysema:
- Destruction of alveolar walls
- Loss of elastic recoil
- Air trapping
- "Pink puffer" appearance (pursed-lip breathing, barrel chest)
Risk Factors
- Smoking (primary cause - 85-90% of cases)
- Alpha-1 antitrypsin deficiency
- Occupational dust and chemical exposure
- Air pollution
- Recurrent respiratory infections
Clinical Manifestations
| Finding | Description |
|---|---|
| Dyspnea | Progressive shortness of breath, especially with exertion |
| Chronic Cough | Productive, especially in chronic bronchitis |
| Barrel Chest | Increased AP diameter from air trapping |
| Prolonged Expiration | Difficulty exhaling due to airway obstruction |
| Use of Accessory Muscles | Neck and shoulder muscles during breathing |
| Pursed-Lip Breathing | Compensatory technique to exhale CO2 |
| Tripod Position | Leaning forward with hands on knees |
| Wheezing | High-pitched sounds on expiration |
| Clubbing | Chronic hypoxia indicator |
The Hypoxic Drive Concept
Critical Concept: In advanced COPD, patients may lose their normal respiratory drive (response to high CO2) and instead rely on low oxygen levels to stimulate breathing.
Implications for Oxygen Therapy:
- Use low-flow oxygen (1-2 L/min via nasal cannula)
- Target SpO2: 88-92% (not 100%)
- High-flow oxygen may suppress respiratory drive
- Monitor closely for hypoventilation and CO2 retention
- Watch for signs of CO2 narcosis: confusion, lethargy, decreased LOC
COPD Medications
Bronchodilators:
| Type | Examples | Action |
|---|---|---|
| Short-acting beta-agonists (SABA) | Albuterol | Rapid relief, "rescue" inhaler |
| Long-acting beta-agonists (LABA) | Salmeterol, formoterol | Maintenance, use twice daily |
| Anticholinergics (SAMA/LAMA) | Ipratropium, tiotropium | Reduce secretions, bronchodilation |
Anti-inflammatory:
- Inhaled corticosteroids (ICS): Fluticasone, budesonide
- Oral corticosteroids for exacerbations
Combination Inhalers:
- LABA + ICS
- LABA + LAMA
Nursing Interventions for COPD
Breathing Techniques:
- Pursed-lip breathing: Inhale through nose, exhale slowly through pursed lips (like blowing out a candle)
- Prolongs exhalation, prevents airway collapse, helps exhale trapped CO2
- Diaphragmatic breathing: Focus on belly rising with inspiration
Positioning:
- High Fowler's or orthopneic position (leaning forward)
- Reduces work of breathing
- Allows diaphragm to move freely
Energy Conservation:
- Rest periods between activities
- Pace activities throughout the day
- Use assistive devices as needed
Infection Prevention:
- Annual influenza vaccine
- Pneumococcal vaccine
- Avoid crowds during flu season
- Hand hygiene
COPD Exacerbation
An acute worsening of symptoms, often triggered by infection.
Signs of Exacerbation
- Increased dyspnea
- Change in sputum (volume, color, thickness)
- Increased cough
- Fever
- Confusion (hypoxia or CO2 retention)
Treatment
- Bronchodilators: Albuterol nebulizer treatments
- Corticosteroids: Prednisone 40-60 mg daily for 5-7 days
- Antibiotics: If bacterial infection suspected (purulent sputum)
- Oxygen: Titrate to maintain SpO2 88-92%
- BiPAP: For respiratory failure to avoid intubation
Pneumonia
Pneumonia is an acute infection of the lung parenchyma causing inflammation and consolidation.
Types of Pneumonia
| Type | Description |
|---|---|
| Community-Acquired (CAP) | Acquired outside healthcare settings |
| Hospital-Acquired (HAP) | Develops > 48 hours after admission |
| Ventilator-Associated (VAP) | Develops > 48 hours after intubation |
| Aspiration | Inhalation of oral/gastric contents |
Common Pathogens
| Setting | Organisms |
|---|---|
| CAP | Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma |
| HAP/VAP | Pseudomonas, MRSA, Gram-negative bacteria |
| Aspiration | Mixed anaerobes, Gram-negative |
| Immunocompromised | Pneumocystis jiroveci, fungal organisms |
Clinical Manifestations
Typical Pneumonia:
- Fever, chills
- Productive cough (purulent, rust-colored, or green sputum)
- Pleuritic chest pain (sharp, worse with inspiration)
- Tachypnea, tachycardia
- Crackles on auscultation
- Diminished breath sounds over affected area
- Dullness to percussion (consolidation)
Atypical Pneumonia:
- Gradual onset
- Dry, nonproductive cough
- Lower fever
- Headache, myalgias
- Often caused by Mycoplasma, Chlamydia, or Legionella
Diagnostic Tests
| Test | Purpose |
|---|---|
| Chest X-ray | Confirms infiltrate/consolidation |
| Sputum Culture | Identifies organism (obtain before antibiotics if possible) |
| Blood Cultures | For bacteremia detection |
| CBC | Elevated WBC indicates infection |
| Procalcitonin | Elevated in bacterial pneumonia |
| Pulse Oximetry/ABG | Assess oxygenation |
Treatment of Pneumonia
Antibiotics:
- Empiric therapy started based on likely pathogens
- Adjust based on culture results
- CAP: Macrolide (azithromycin) or respiratory fluoroquinolone
- HAP/VAP: Broader coverage including anti-pseudomonal agents
Supportive Care:
- Oxygen therapy to maintain SpO2 > 92%
- IV fluids if dehydrated
- Antipyretics for fever
- Adequate rest
Nursing Interventions for Pneumonia
Airway Clearance:
- Encourage fluids (2-3 L/day if not contraindicated) to thin secretions
- Humidified oxygen
- Chest physiotherapy if ordered
- Incentive spirometry every 1-2 hours while awake
- Splint chest when coughing
Positioning:
- Semi-Fowler's or high Fowler's position
- Turn every 2 hours
- "Good lung down" for unilateral pneumonia (promotes V/Q matching)
Prevention of Complications:
- Early mobilization
- DVT prophylaxis
- Hand hygiene and isolation if indicated
- Monitor for sepsis development
Comparison: COPD vs. Pneumonia
| Feature | COPD | Pneumonia |
|---|---|---|
| Type | Chronic condition | Acute infection |
| Onset | Progressive | Acute |
| Fever | Usually absent unless exacerbation | Usually present |
| Cough | Chronic | Acute, productive |
| Lung Sounds | Wheezes, diminished | Crackles, bronchial sounds |
| Chest X-ray | Hyperinflation | Infiltrate/consolidation |
| O2 Therapy | Low flow (1-2 L/min) | As needed for SpO2 > 92% |
Key Points for the NCLEX
- COPD: Low-flow oxygen (1-2 L/min), target SpO2 88-92%
- Pursed-lip breathing helps exhale trapped CO2 in COPD
- Pneumonia: Encourage fluids to thin secretions
- Incentive spirometry prevents atelectasis and complications
- Crackles = pneumonia (fluid in alveoli)
- Wheezes = COPD/asthma (airway narrowing)
- Obtain sputum culture before antibiotics when possible
- "Good lung down" positioning for unilateral pneumonia
A patient with severe COPD has an SpO2 of 86% on room air. What is the appropriate oxygen delivery method?
Which breathing technique should the nurse teach a patient with COPD to help with exhalation?
A patient with pneumonia has thick, tenacious secretions. Which intervention is most important?